Cargando…
Severe hepatitis E infection in pregnancy: a case report
Hepatitis E virus causes self limiting hepatitis most of the times but, during pregnancy it can lead to severe hepatitis along with various complications thereby increasing the mortality. CASE PRESENTATION: A 27-year-old woman gravida two, para one at 38 weeks and 6 days of gestation presented with...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129118/ https://www.ncbi.nlm.nih.gov/pubmed/37113858 http://dx.doi.org/10.1097/MS9.0000000000000449 |
_version_ | 1785030660179623936 |
---|---|
author | Jha, Kritika Tandukar, Alina Aryal, Roshan Shrestha, Prezma Bajracharya, Sunita Bista, Kesang D. |
author_facet | Jha, Kritika Tandukar, Alina Aryal, Roshan Shrestha, Prezma Bajracharya, Sunita Bista, Kesang D. |
author_sort | Jha, Kritika |
collection | PubMed |
description | Hepatitis E virus causes self limiting hepatitis most of the times but, during pregnancy it can lead to severe hepatitis along with various complications thereby increasing the mortality. CASE PRESENTATION: A 27-year-old woman gravida two, para one at 38 weeks and 6 days of gestation presented with multiple episodes of nonbilious vomiting, severe dehydration, and later developed right upper quadrant abdominal pain. The patient had a positive serological test for the hepatitis E virus, and liver enzymes were severely elevated. Under supportive treatment she delivered a healthy baby, and her liver enzymes returned to normal levels after 2 weeks of delivery. CLINICAL DISCUSSION: Although the hepatitis E virus usually causes self-limiting hepatitis, it can quickly progress to severe hepatitis, liver failure, and even death during pregnancy. Immunological change with a Th2 biased response and increased hormonal levels during pregnancy could possibly facilitate the development of severe liver damage. No particular drug has been approved for the treatment of hepatitis E viral infection in pregnant women, and the commonly used drugs are contraindicated due to the risk of teratogenicity. Supportive therapy and intensive monitoring are the core management techniques for hepatitis E virus infection in pregnant women. CONCLUSION: Due to the high mortality risk, pregnant women should try to avoid possible exposure to the hepatitis E virus, but once infected, symptomatic therapy is the mainstay. |
format | Online Article Text |
id | pubmed-10129118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101291182023-04-26 Severe hepatitis E infection in pregnancy: a case report Jha, Kritika Tandukar, Alina Aryal, Roshan Shrestha, Prezma Bajracharya, Sunita Bista, Kesang D. Ann Med Surg (Lond) Case Reports Hepatitis E virus causes self limiting hepatitis most of the times but, during pregnancy it can lead to severe hepatitis along with various complications thereby increasing the mortality. CASE PRESENTATION: A 27-year-old woman gravida two, para one at 38 weeks and 6 days of gestation presented with multiple episodes of nonbilious vomiting, severe dehydration, and later developed right upper quadrant abdominal pain. The patient had a positive serological test for the hepatitis E virus, and liver enzymes were severely elevated. Under supportive treatment she delivered a healthy baby, and her liver enzymes returned to normal levels after 2 weeks of delivery. CLINICAL DISCUSSION: Although the hepatitis E virus usually causes self-limiting hepatitis, it can quickly progress to severe hepatitis, liver failure, and even death during pregnancy. Immunological change with a Th2 biased response and increased hormonal levels during pregnancy could possibly facilitate the development of severe liver damage. No particular drug has been approved for the treatment of hepatitis E viral infection in pregnant women, and the commonly used drugs are contraindicated due to the risk of teratogenicity. Supportive therapy and intensive monitoring are the core management techniques for hepatitis E virus infection in pregnant women. CONCLUSION: Due to the high mortality risk, pregnant women should try to avoid possible exposure to the hepatitis E virus, but once infected, symptomatic therapy is the mainstay. Lippincott Williams & Wilkins 2023-04-06 /pmc/articles/PMC10129118/ /pubmed/37113858 http://dx.doi.org/10.1097/MS9.0000000000000449 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Case Reports Jha, Kritika Tandukar, Alina Aryal, Roshan Shrestha, Prezma Bajracharya, Sunita Bista, Kesang D. Severe hepatitis E infection in pregnancy: a case report |
title | Severe hepatitis E infection in pregnancy: a case report |
title_full | Severe hepatitis E infection in pregnancy: a case report |
title_fullStr | Severe hepatitis E infection in pregnancy: a case report |
title_full_unstemmed | Severe hepatitis E infection in pregnancy: a case report |
title_short | Severe hepatitis E infection in pregnancy: a case report |
title_sort | severe hepatitis e infection in pregnancy: a case report |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129118/ https://www.ncbi.nlm.nih.gov/pubmed/37113858 http://dx.doi.org/10.1097/MS9.0000000000000449 |
work_keys_str_mv | AT jhakritika severehepatitiseinfectioninpregnancyacasereport AT tandukaralina severehepatitiseinfectioninpregnancyacasereport AT aryalroshan severehepatitiseinfectioninpregnancyacasereport AT shresthaprezma severehepatitiseinfectioninpregnancyacasereport AT bajracharyasunita severehepatitiseinfectioninpregnancyacasereport AT bistakesangd severehepatitiseinfectioninpregnancyacasereport |